4th Quarter - Report

CAPITOL HILL STRATEGIES, LLC for BIOGEN INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

H.R. 9, Innovation Act (Inter partes review provisions and other provisions relating to patents covered by Hatch-Waxman and Biologics Price Competition and Innovation Act (BPCIA) S.632, Support Technology and Research for Our Nation's Growth Patents Act of 2015

LobbyistCovered position, as disclosed
CHARLES M BRAIN Asst. to the President, Dp.Chief Staff W&M Cmte
HEATHER MCHUGH Legislative Director, Sen. Chuck Schumer
BEAU` SCHUYLER LD-CongTanner,LD-CongMcIntyre,SA-CongRose
A. J. WOJCIAK Senior Legislative Asst., Cong. Earl Pomeroy

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 9 (114th), S. 632 (114th)

Medical/Disease Research/Clinical Labs MED

H.R. 6, 21st Century Cures Act, (multiple provisions including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets) Senate Innovations for Healthy Americans Act (text not yet available but likely multiple provisions similar to H.R. 6 including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets)

LobbyistCovered position, as disclosed
CHARLES M BRAIN Asst. to the President, Dp.Chief Staff W&M Cmte
HEATHER MCHUGH Legislative Director, Sen. Chuck Schumer
BEAU` SCHUYLER LD-CongTanner,LD-CongMcIntyre,SA-CongRose
A. J. WOJCIAK Senior Legislative Asst., Cong. Earl Pomeroy

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.